BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30041549)

  • 1. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Solanky D; Pardi DS; Loftus EV; Khanna S
    Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
    Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
    Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
    BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
    Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
    Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and clinical characteristics of Clostridium difficile infection in Saudi patients admitted with inflammatory bowel disease: A case-control study.
    AlKhormi A; Altheyabi AM; AlGhamdi SA; Alshahrani O; Alotay AA; Deeb A
    Saudi J Gastroenterol; 2023; 29(4):251-255. PubMed ID: 37282448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
    Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
    J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Cho S; Spencer E; Hirten R; Grinspan A; Dubinsky MC
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):343-347. PubMed ID: 30320666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: Clostridium difficile and inflammatory bowel disease.
    Goodhand JR; Alazawi W; Rampton DS
    Aliment Pharmacol Ther; 2011 Feb; 33(4):428-41. PubMed ID: 21198703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.